eli lilly ceo david ricks on q1 earnings: this will be a year of both growth and investment
Published 1 year ago • 3K plays • Length 3:39Download video MP4
Download video MP3
Similar videos
-
4:29
eli lilly ceo david ricks breaks down q1 earnings, obesity drug trial results
-
5:33
eli lilly ceo david ricks on 3-year obesity drug study: this is a profound result
-
6:05
eli lilly ceo david ricks on q2 results: seeing unbelievable demand for zepbound and mounjaro
-
4:12
eli lilly ceo david ricks explains q1 earnings miss, lowered forecast
-
4:26
eli lilly ceo david ricks breaks down second-quarter earnings and drug pipeline
-
3:00
eli lilly is becoming the 'goat' of obesity, says bmo's evan seigerman
-
3:30
goldman sachs raises target on eli lilly: here's why
-
4:19
eli lilly is a 'great destination for investors', says deutsche bank's james shin after upgrade
-
6:43
eli lilly ceo on weight loss drugs outlook: our top priority is making more product
-
8:11
eli lilly ceo david ricks on q3 earnings beat, mounjaro strength
-
4:14
eli lilly ceo david ricks on glp-1 and obesity drugs
-
30:33
eli lilly ceo dave ricks on revolutionizing healthcare and medicine
-
4:05
vast utility for weight loss drugs will more than pay for themselves, says eli lilly ceo david ricks
-
6:11
leerink's david risinger talks eli lilly seeing best trading day in a year after earnings
-
2:59
3-stock lunch: nvidia, eli lilly, paramount
-
7:33
watch cnbc's full interview with eli lilly ceo david ricks
-
0:55
eli lilly ceo on compounded versions of weight loss drugs
-
5:50
eli lilly ceo: we expect to launch five new medicines in 2022
-
6:08
eli lilly ceo on slashing insulin prices, approval timelines for weight-loss and alzheimer's drugs
-
5:01
eli lilly ceo weighs in on q4 revenue miss
-
6:32
eli lilly ceo: drug pricing bill would 'fundamentally restructure' company
-
3:46
eli lilly ceo david ricks on positive alzheimer's drug trial data